La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Inflammation »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Infirmité motrice cérébrale < Inflammation < Influenzavirus A  Facettes :

List of bibliographic references indexed by Inflammation

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000B80 (2014) Alexandro Gianforcaro [Canada] ; Mazen J. Hamadeh [Canada]Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis
001491 (2012) R. B. Laprairie [Canada] ; M. E. M. Kelly [Canada] ; E. M. Denovan-Wright [Canada]The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription : Cannabinoids 2012
001525 (2012) D. W. Luchtman [Canada] ; Q. Meng [Canada] ; C. Song [Canada, République populaire de Chine]Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease
001532 (2012) Tyler Bassett [Canada] ; Paxton Bach [Canada] ; Hing Man Chan [Canada]Effects of methylmercury on the secretion of pro-inflammatory cytokines from primary microglial cells and astrocytes
001935 (2011) Shivraj S. Jhala [Canada] ; Alan S. Hazell [Canada]Modeling neurodegenerative disease pathophysiology in thiamine deficiency: Consequences of impaired oxidative metabolism
001D17 (2010) QINGJIA MENG [Canada] ; Dirk W. Luchtman [Canada] ; BOUCHAIB EL BAHH [Canada] ; Jeffrey A. Zidichouski [Canada] ; JUN YANG [Canada] ; CAI SONG [Canada]Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices
002092 (2009) Emily N. Mangano [Canada] ; Shawn Hayley [Canada]Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration
002117 (2009) Dirk W. Luchtman [Canada] ; DI SHAO [Canada] ; CAI SONG [Canada]Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease
002317 (2008) Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada]Glial reactions in Parkinson's disease
002627 (2007) Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada]The role of anti-inflammatory agents in Parkinson's disease
002905 (2006) J. Miklossy [Canada] ; D. D. Doudet [Canada] ; C. Schwab [Canada] ; S. Yu [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]Role of ICAM-1 in persisting inflammation in parkinson disease and MPTP monkeys
002B20 (2005) Edith G. Mcgeer [Canada] ; Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada]Inflammation, the complement system and the diseases of aging
002D46 (2004) Kerry B. Goralski [Canada] ; Kenneth W. Renton [Canada]Brain inflammation enhances 1-methyl-4-phenylpyridinium-evoked neurotoxicity in rats
002F35 (2003) ZHIGAO HUANG [Canada] ; Raul De La Fuente-Fernandez [Canada] ; A. Jon Stoessl [Canada]Etiology of Parkinson's disease
003096 (2002) Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada]Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity
003101 (2002) Patrick L. Mcgeer [Canada] ; Koji Yasojima [Canada] ; Edith G. Mcgeer [Canada]Association of interleukin-1β polymorphisms with idiopathic Parkinson's disease
003309 (2001) Patrick L. Mcgeer [Canada] ; Koji Yasojima [Canada] ; Edith G. Mcgeer [Canada]Inflammation in Parkinson's disease
003334 (2001) Moussa B. H. Youdim [Israël] ; Edna Grünblatt [Israël] ; Yona Levites-Royak [Israël] ; Silvia Mandel [Israël]Drugs to prevent cell death in Parkinson's disease: Neuroprotection against oxidative stress and inflammatory gene expression
003401 (2000) X. Lu [Canada] ; G. Bing [États-Unis] ; T. Hagg [Canada]Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats
003581 (2000) Nancy J. Rothwell [Royaume-Uni] ; Giamal N. Luheshi [Canada]Interleukin I in the brain : biology, pathology and therapeutic target
003A40 (1998) P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada]Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Inflammation" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Inflammation" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Inflammation
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022